CMRA — Comera Life Sciences Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $0.77m
- -$1.00m
- $0.63m
Annual cashflow statement for Comera Life Sciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -2.13 | -5.45 | -18 |
| Depreciation | |||
| Non-Cash Items | 0.274 | 1.03 | 5.59 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.042 | 0.574 | 2.55 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -1.8 | -3.76 | -9.77 |
| Capital Expenditures | -0.012 | -0.142 | -0.029 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -0.012 | -0.142 | -0.029 |
| Financing Cash Flow Items | — | — | 0.445 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 1.55 | 10.3 | 5.24 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.264 | 6.38 | -4.56 |